7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5)

Tzu Sheng Hsu; Chinpiao Chen; Pei Ting Lee; Shu Jun Chiu; Huei Fang Liu; Chih Chien Tsai; Jui-I Chao

doi:10.1007/s00280-008-0718-6

7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5)

Tzu Sheng Hsu, Chinpiao Chen, Pei Ting Lee, Shu Jun Chiu, Huei Fang Liu, Chih Chien Tsai, Jui-I Chao^*

^*Corresponding author for this work

Department of Biological Science and Technology

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Number of pages	1
Journal	Cancer Chemotherapy and Pharmacology
Volume	62
Issue number	5
DOIs	https://doi.org/10.1007/s00280-008-0718-6
State	Published - 1 Oct 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00280-008-0718-6

Cite this

Hsu, T. S., Chen, C., Lee, P. T., Chiu, S. J., Liu, H. F., Tsai, C. C., & Chao, J.-I. (2008). 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5). Cancer Chemotherapy and Pharmacology, 62(5). https://doi.org/10.1007/s00280-008-0718-6

Hsu, Tzu Sheng ; Chen, Chinpiao ; Lee, Pei Ting et al. / 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI : 10.1007/s00280-007-0667-5). In: Cancer Chemotherapy and Pharmacology. 2008 ; Vol. 62, No. 5.

@article{9d94f20b418a4dc19bcf6c5a59bcc8a5,

title = "7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5)",

author = "Hsu, {Tzu Sheng} and Chinpiao Chen and Lee, {Pei Ting} and Chiu, {Shu Jun} and Liu, {Huei Fang} and Tsai, {Chih Chien} and Jui-I Chao",

year = "2008",

month = oct,

day = "1",

doi = "10.1007/s00280-008-0718-6",

language = "English",

volume = "62",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Verlag",

number = "5",

}

Hsu, TS, Chen, C, Lee, PT, Chiu, SJ, Liu, HF, Tsai, CC & Chao, J-I 2008, '7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5)', Cancer Chemotherapy and Pharmacology, vol. 62, no. 5. https://doi.org/10.1007/s00280-008-0718-6

7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5). / Hsu, Tzu Sheng; Chen, Chinpiao; Lee, Pei Ting et al.
In: Cancer Chemotherapy and Pharmacology, Vol. 62, No. 5, 01.10.2008.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI

T2 - 10.1007/s00280-007-0667-5)

AU - Hsu, Tzu Sheng

AU - Chen, Chinpiao

AU - Lee, Pei Ting

AU - Chiu, Shu Jun

AU - Liu, Huei Fang

AU - Tsai, Chih Chien

AU - Chao, Jui-I

PY - 2008/10/1

Y1 - 2008/10/1

UR - http://www.scopus.com/inward/record.url?scp=49749085190&partnerID=8YFLogxK

U2 - 10.1007/s00280-008-0718-6

DO - 10.1007/s00280-008-0718-6

M3 - Comment/debate

AN - SCOPUS:49749085190

SN - 0344-5704

VL - 62

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

IS - 5

ER -

Hsu TS, Chen C, Lee PT, Chiu SJ, Liu HF, Tsai CC et al. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5). Cancer Chemotherapy and Pharmacology. 2008 Oct 1;62(5). doi: 10.1007/s00280-008-0718-6

7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway (Cancer Chemotherapy and Pharmacology DOI: 10.1007/s00280-007-0667-5)

UN SDGs

Access to Document

Other files and links

Cite this